Cboe UK CHF

medmix AG (MEDXZ.XC)

Compare
10.50
+0.30
+(2.94%)
As of 2:37:41 PM GMT. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.
NameTitlePayExercisedYear Born
Ms. Jennifer Dean Chief Financial Officer -- -- 1968
Ms. Sheel Gill Head of M&A, Strategy & Investor Relations -- -- --
Mr. Schops Xavier Chief Legal Officer, Company Secretary & Head of Corporate Affairs -- -- 1968
Ms. Itee Satpathy Chief Human Resources & Sustainability Officer -- -- 1978
Ms. Ayse Sanlioglu Global Head of Business Unit Dental -- -- --
Mr. Roman Thoenig Global Head Business Segment Industry -- -- --
Mr. Oliver Vogel Global Head Business Segment Beauty -- -- --
Mr. Dominik Vonier Global Head Business Segment Drug Delivery -- -- --
Ms. Kara Zweizig Head of Business Segment Surgery -- -- --

medmix AG

Neuhofstrasse 20
Baar, 6340
Switzerland
41 41 723 7375 https://www.medmix.swiss
Sector: 
Industrials
Full Time Employees: 
2,695

Description

medmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. The company operates through Dental, Drug Delivery, Surgery, Industry, and Beauty segments. The company offers dental products, including mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, adhesives, restoratives, prevention, esthetics and endodontics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and DIY industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Baar, Switzerland.

Corporate Governance

medmix AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

April 26, 2024 at 12:00 AM UTC

Ex-Dividend Date